To investigate the potential reversal of RCC resistance to sunitinib by knocking down DEPDC1, sunitinib-resistant 786-O cell (786-O-R) was established by using CCK8 assays (Fig. 4a). The gene discussed is DEPDC1; the disease is renal cell carcinoma.